Lupus Patients Face High Rehospitalization Rates

Drugs that suppress the immune system make it harder to fight infection, study says

From the WebMD Archives

By Tara Haelle

HealthDay Reporter

MONDAY, Aug. 11, 2014 (HealthDay News) -- One in six hospitalized lupus patients requires readmission to the hospital within a month after discharge, according to a new study.

While patients' disease severity contributed to readmission rates, other population differences suggest hospitals might be able to reduce rehospitalizations through better discharge plans and by addressing disparities in health care, said Dr. Jinoos Yazdany, lead researcher and associate professor of medicine at the University of California, San Francisco.

Lupus is a disease in which the immune system attacks the body. Although researchers don't understand all of its causes, there is a genetic component to the disease, Yazdany said. Drugs that suppress the immune system can help control lupus but often with bad side effects.

Lupus afflicts approximately 10 times more women than men and disproportionately affects racial and ethnic minorities and lower socioeconomic groups, she said.

"There are likely environmental, psychosocial, biological and even health care factors that play a role," Yazdany said. "No one strategy is going to be enough to eliminate these differences we see in lupus prevalence."

For the study, published online Aug. 11 in Arthritis & Rheumatology, Yazdany's team analyzed hospital discharge records in 2008 and 2009 for about 32,000 patients from more than 800 hospitals in New York, Florida, Utah, California and Washington.

Causes of initial hospitalization generally fell into three categories, Yazdany said. The first arose from the disease itself, such as inflammation or organ failure. The second resulted from other conditions, such as heart disease or diabetes, which commonly coexist with lupus.

The last category included infections. The same drugs that suppress the immune system so that lupus can't attack the body also reduce a person's ability to fight off bacterial and viral infections.

These reasons also provide clues regarding the study's finding that 16.5 percent of patients were readmitted to the hospital within 30 days.

"If you have more severe manifestations of the lupus that brought you to the hospital, you're going to be treated with aggressive immunosuppressants, and that's going to increase your risk of infection," said Dr. Joan Merrill, medical director of the Lupus Foundation of America and head of clinical pharmacology research at Oklahoma Medical Research Foundation. "That's going to increase your risk of rehospitalization, and/or if the treatments don't work, then you're at risk of organ failure."